No abstract available
MeSH terms
-
Advisory Committees
-
Anticoagulants / therapeutic use*
-
Atrial Fibrillation / drug therapy*
-
Clinical Trials as Topic
-
Drug Approval / legislation & jurisprudence*
-
Government Regulation*
-
Humans
-
Morpholines / therapeutic use*
-
Rivaroxaban
-
Thiophenes / therapeutic use*
-
United States
-
United States Food and Drug Administration
Substances
-
Anticoagulants
-
Morpholines
-
Thiophenes
-
Rivaroxaban